- $8.58m
- $34.74m
- $80.68m
- 11
- 89
- 26
- 37
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 0.37 | ||
Price to Tang. Book | 3.99 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 0.1 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -50.97% | ||
Return on Equity | -61.6% | ||
Operating Margin | -21.18% |
Financial Summary
Year End 30th Jun | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | 2.21 | 7.41 | 24.1 | 23.07 | 80.68 | 94.11 | 101.71 | 145.86% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Upexi, Inc. is a multi-faceted brand owner with brands in the health, wellness, pet, beauty, and other growing markets. The Company focuses on direct-to-consumer and Amazon brands. The Company utilizes its in-house software-as-a-service (SaaS) programmatic advertising technology to help achieve a lower cost per acquisition and accumulate consumer data for increased cross-selling between its growing portfolio of brands. Its Branded Product segment is focused on the development, growth, and distribution of the branded products that the Company own. Its Recommerce segment is focused on the purchase and sale of new and used products through channels, such as Amazon and wholesale distributors. The Company’s brands include VitaMedica, Tytan Tiles, and others. VitaMedica offers clinician-originated nutraceuticals and cosmeceuticals products. VitaMedica’s sales model includes wholesale distribution through surgeons and med spas and direct to consumers through e-commerce and marketplaces.
Directors
- Last Annual
- June 30th, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- September 5th, 2018
- Public Since
- June 24th, 2021
- No. of Shareholders
- 4,152
- No. of Employees
- 95
- Sector
- Software & IT Services
- Industry
- Technology
- Exchange
NASDAQ Capital Market
- Shares in Issue
- 20,817,566
![Blurred out image of a map](https://www.stockopedia.com/assets/conversion/images/maps_placeholder.jpg)
- Address
- 3030 Rocky Point Drive, Suite 420, TAMPA, 33607
- Web
- https://upexi.com/
- Phone
- +1 7013535425
- Contact
- Valter Pinto
- Auditors
- BF Borgers CPA PC
Upcoming Events for UPXI
Similar to UPXI
Abits
NASDAQ Capital Market
Ads-Tec Energy
NASDAQ Capital Market
AdTheorent Holding
NASDAQ Capital Market
Advanced Health Intelligence
NASDAQ Capital Market
AGM group
NASDAQ Capital Market
FAQ
As of Today at 23:56 UTC, shares in Upexi are trading at $0.45. This share price information is delayed by 15 minutes.
Shares in Upexi last closed at $0.45 and the price had moved by -80.28% over the past 365 days. In terms of relative price strength the Upexi share price has underperformed the S&P500 Index by -84.31% over the past year.
The overall consensus recommendation for Upexi is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Upexi does not currently pay a dividend.
Upexi does not currently pay a dividend.
Upexi does not currently pay a dividend.
To buy shares in Upexi you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.45, shares in Upexi had a market capitalisation of $9.40m.
Here are the trading details for Upexi:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: UPXI
Based on an overall assessment of its quality, value and momentum Upexi is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Upexi is $1.25. That is 176.85% above the last closing price of $0.45.
Analysts covering Upexi currently have a consensus Earnings Per Share (EPS) forecast of -$0.35 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Upexi. Over the past six months, its share price has underperformed the S&P500 Index by -63.13%.
As of the last closing price of $0.45, shares in Upexi were trading -51.76% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Upexi PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.45.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Upexi's directors